Chemicals and Life Sciences Tracker
Transactions and Joint Ventures

Coromandel International to Acquire 53% Stake in NACL Industries for $94M

Coromandel International has signed definitive agreements to acquire a 53% stake in NACL Industries for Rs 820 crores ($94M) at Rs 76.7 per share from current promoter KLR Products Limited. This acquisition strengthens Coromandel’s position in India’s crop protection industry, expanding its technical capabilities, contract manufacturing presence, and domestic formulation footprint, with plans to launch an open offer for an additional 26% stake.

Clario Successfully Acquires NeuroRx

Clario has acquired NeuroRx, a leading imaging analysis company specialising in multiple sclerosis, to enhance its neuroscience expertise. NeuroRx has provided imaging services for over 300 clinical trials and supported approvals for 12 FDA-approved multiple sclerosis drugs, with founder Douglas Arnold joining Clario as senior scientific advisor.

Taiho Acquires Araris Biotech in Potential $1.1B Deal

Taiho Pharmaceutical has entered into a definitive agreement to acquire Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, for $400 million upfront and up to $740 million in milestone payments. This acquisition strengthens Taiho’s oncology pipeline by integrating Araris’ innovative ADC platform with its proprietary small molecule drug discovery technology, Cysteinomix.

iOncologi Acquires TargImmune Therapeutics

iOncologi has acquired TargImmune Therapeutics, a biotechnology company specialising in tumour-targeted immunotherapies, significantly strengthening its immunotherapy capabilities. TargImmune will continue operating in Basel, Switzerland, as a wholly owned subsidiary, ensuring continuity in its research on novel tumour-targeted RNA therapies while benefiting from iOncologi’s expanded resources.

Advanced Instruments to Acquire and Merge with Nova Biomedical

Advanced Instruments, a Patricia Industries subsidiary, has signed a definitive agreement to acquire Nova Biomedical, merging under the Nova Biomedical name. The combined business will create a global life sciences tools platform with a diversified portfolio of analytical instruments, reagents, and services. Byron Selman, CEO of Advanced Instruments, will lead the company, while Nova Biomedical’s founding shareholders will remain as consultants. 

BioReNuva Announces Strategic Investment From Hallstar

BioReNuva has secured an investment from Hallstar, a specialty chemical supplier for the beauty and personal care industry, to accelerate its biosynthesis capabilities. The Austin-based biotechnology company develops glycolipids from common oils, enhancing safety and sustainability. This investment will support technical development, production capacity, and market expansion across multiple verticals.

Blackstone Acquires Majority Stake in CMIC Group

Blackstone has entered into a definitive agreement to acquire a 60% stake in CMIC, Japan’s leading contract research organisation, with CMIC HOLDINGS retaining the remaining 40%. This investment aligns with Blackstone’s focus on Japan’s healthcare sector, leveraging its expertise and network to support CMIC’s growth and enhance its role in accelerating drug development.

Sun Pharmaceuticals Acquires Checkpoint Therapeutics

Sun Pharma has agreed to acquire Checkpoint Therapeutics, a Nasdaq-listed oncology company, for an upfront payment of $355 million, with stockholders receiving an additional contingent value right. This acquisition adds UNLOXCYT™ (cosibelimab-ipdl), an FDA-approved treatment for metastatic cutaneous squamous cell carcinoma, to Sun Pharma’s global oncology portfolio, strengthening its presence in immunotherapy.

Mitsui O.S.K. Lines (MOL) to Acquire LBC Tank Terminals for $1.72bn

Mitsui O.S.K. Lines has signed an agreement to acquire LBC Tank Terminals, a global independent operator specialising in chemical storage, for approximately $1.72 billion. This acquisition expands MOL’s chemical logistics business, adding onshore storage capabilities to its maritime transport and positioning it as a leader in total chemical logistics services.

Clario Acquires WCG's eCOA Business

Clario has entered into an agreement to acquire WCG’s electronic clinical outcome assessments (eCOA) business, expanding its capabilities in neuroscience. This acquisition strengthens Clario’s position in clinical trial endpoint data solutions, enhancing its ability to support drug safety and efficacy assessments.

Syngene Acquires US Drug Substance Manufacturing Facility from Emergent BioSolutions

Emergent BioSolutions has entered into an agreement to sell its Baltimore-Bayview drug substance manufacturing facility to Syngene for $36.5 million. The Bayview site includes manufacturing, laboratory, warehousing, and office space, with multiple monoclonal antibody (mAbs) manufacturing lines, while Emergent will retain the rights to secure manufacturing services at the facility for future growth and pandemic response production.

Samsung E&A Acquires 9.1% Stake in Nel ASA

Samsung E&A has acquired a 9.1% stake in Norwegian hydrogen company Nel ASA for approximately $33 million and signed a strategic partnership agreement. This collaboration aims to develop an integrated technology solution for hydrogen production plants, positioning Samsung E&A at the forefront of the green hydrogen market.

OMV and ADNOC Merge Borealis/Borouge and Acquire Nova Chemicals

OMV and ADNOC have announced the merger of Borealis and Borouge to create Borouge Group International, which will acquire Nova Chemicals for $13.4 billion. This merger forms the world’s fourth-largest polyolefins producer, enhancing both companies' global market presence and delivering significant synergies and growth opportunities in the chemicals sector.

Shell Considers Sale of Chemical Assets in US, Europe

Shell is contemplating the sale of its chemical assets in the US and Europe as reported by the Wall Street Journal, with Morgan Stanley handling a strategic review. This potential divestment, part of Shell’s broader strategy under CEO Wael Sawan, aims to enhance focus on higher-margin businesses while reducing exposure to the chemicals sector, including its Deer Park plant in Texas and other facilities across multiple countries.

Sika Acquires Cromar Building Products

Sika has successfully acquired Cromar Building Products, a leading supplier of roofing systems in the UK. The acquisition expands Sika’s reach in the UK roofing sector, offering significant cross-selling opportunities and aligning with its ongoing growth in building materials, especially in the distribution channel.

Sika Acquires HPS North America

Sika has fully acquired HPS North America, a well-established supplier of building finishing materials in the US. This acquisition, which follows Sika’s previous minority stake in HPS, strengthens its position in the building finishing market, enhancing efficiency and unlocking cross-selling opportunities in flooring solutions.

WE Soda Acquires Genesis Alkali  

WE Soda has acquired Genesis Alkali, the largest US-based producer of natural soda ash, for $1.4 billion. This strategic acquisition strengthens WE Soda’s position as the world’s leading soda ash producer, boosting production capacity to 9.5 million metric tonnes annually and enhancing its sustainability leadership.

Azzurra Capital Acquires 8% Stake in NEXTCHEM 

Azzurra Capital has acquired an 8% stake in NEXTCHEM for €110 million, further strengthening the company’s growth trajectory and strategic positioning. This investment supports NEXTCHEM’s strategy and its role as a leading technology player in the global energy transition sector.

Lone Star Acquires RadiciGroup’s Specialty Chemicals, Performance Polymers Businesses

Lone Star Funds, through its Lone Star Fund XII, L.P., will acquire RadiciGroup’s Specialty Chemicals and High-Performance Polymers businesses. RadiciGroup, founded in 1941 and based in Bergamo, Italy, is a family-owned leader in the polyamides (nylon) value chain, serving markets in Europe, the Americas, and Asia. After the deal, the Radici family will retain the Advanced Textiles Solutions division, focusing on innovation and sustainability.

Asian Paints Sell Indonesian Business to Omega Property Investments for S$7.5m ($5.6m) 

Asian Paints has announced the sale of its Indonesian business to Australia's Omega Property Investments for S$7.5 million ($5.6 million) due to growth challenges after nine years in the market. The company stated that despite various strategic efforts, operations in Indonesia remained sub-scale and had little impact on its international business. The sale will result in a loss of $10.4 million, with the Indonesian assets valued at $19 million as of fiscal year 2024. 

AkzoNobel Proposes Separation of Powder Coatings Business from Indian Subsidiary

Akzo Nobel N.V. has proposed acquiring the powder coatings business and international research centre from its Indian subsidiary, Akzo Nobel India Limited. The move will position AkzoNobel India as a more focused liquid paints and coatings business, fully independent in branding and technology.

MOL Chemical Tankers Merges with Fairfield Chemical Carriers

MOL Chemical Tankers has announced the merger of Fairfield Chemical Carriers into its operations, effective 1 April 2025, pending shareholder approval. MOL Chemical Tankers (MOLCT) aims to leverage the merger to enhance operational efficiency, expand its service network, and provide greater flexibility to stakeholders.

Thermo Fisher Scientific to Acquire Solventum’s Purification and Filtration Business for $4.1bn

Thermo Fisher Scientific has entered into a definitive agreement to acquire Solventum’s purification and filtration business for approximately $4.1 billion in cash. The business currently operates globally with 2,500 employees and generates around $1 billion in annual revenue, enhancing Thermo Fisher’s bioproduction capabilities.

GSK Completes Acquisition of IDRx for Up to $1.15 billion

GSK has completed its acquisition of IDRx, a clinical-stage biopharmaceutical company developing precision therapeutics for gastrointestinal stromal tumours. The deal includes an upfront payment of $1 billion, with an additional $150 million contingent on regulatory approvals, strengthening GSK’s pipeline of targeted cancer treatments.

Maravai LifeSciences Acquires DNA and RNA Business of Officinae Bio

Maravai LifeSciences has completed its acquisition of Officinae Bio’s DNA and RNA business, integrating its AI-driven mRNA design platforms with Maravai’s drug substance manufacturing capabilities. The acquisition provides customers with enhanced expertise and novel technologies to accelerate mRNA sequence optimisation and clinical development.

Granules India Acquires Senn Chemicals for CHF 20 million

Granules India acquired Senn Chemicals for CHF 20 million, gaining expertise in peptide synthesis and a strong CDMO business. This acquisition allows Granules to expand into the peptide therapeutics market, particularly in anti-diabetic and anti-obesity treatments, while enhancing its CDMO capabilities. Granules also benefits from Senn's European presence, R&D capabilities, and a certified manufacturing facility.

Sherwin-Williams to Acquire BASF's Brazilian Architectural Paints Business for $1.15bn

Sherwin-Williams has agreed to acquire BASF's Brazilian decorative paints business for $1.15 billion, which is part of BASF’s Coatings division. This transaction will transfer production sites in Demarchi and Jaboatão, including the Suvinil and Glasu! brands, and around 1,000 employees, subject to competition authority approval.

Hexpol AB Acquires 80% of the Shares in Kabkom Kimya

HEXPOL has signed an agreement to acquire 80% of Kabkom Kimya, Turkey’s largest independent cable compounder in a fast growth market. This acquisition, worth €54 million, expands HEXPOL's capabilities in the fast-growing wire and cable market, leveraging Kabkom’s strong market presence in Turkey and international growth potential.

Flourish Research Announces Acquisition of Diablo Clinical Research

Flourish Research has acquired Diablo Clinical Research, expanding its capabilities in cardiovascular, metabolic, and infectious disease research. This acquisition strengthens Flourish’s geographical presence and enhances its service offerings, ensuring a broader reach and improved patient outcomes.

SABIC Completes $966M Sale of Stake in Bahrain Metals Business

SABIC has completed the sale of its 20.62% stake in Aluminium Bahrain to Ma’aden for approximately $966 million. This strategic divestment supports SABIC's focus on its core chemicals business and long-term sustainable growth, contributing positively to its capital reallocation strategy and EBIDITA performance.

PennWhite India Acquires Defoamer Business from Sicagen India Limited

PennWhite India has acquired the defoamer business from Sicagen India, further expanding its presence in the specialty chemicals sector. The acquisition, effective February 14, 2025, strengthens PennWhite’s product portfolio and bolsters its position in key markets, driving growth and innovation.

AsiaPak Investments and Montage Oil DMCC to Acquire Majority Stake in Lotte Chemical Pakistan Limited

AsiaPak Investments and Montage Oil DMCC have announced plans to acquire a 75.01% stake in Lotte Chemical Pakistan for $68 million. The acquisition is part of Lotte Chemical’s strategic shift towards specialty businesses and aims to enhance profitability and operational efficiency, especially in a competitive global PTA market.

BP Europa SE to Seek Potential Buyers for Ruhr Oel GmbH

BP Europa SE has announced its intention to sell Ruhr Oel GmbH – BP Gelsenkirchen, including its refinery assets and DHC Solvent Chemie GmbH in Mülheim an der Ruhr. The sales process will begin immediately, with agreements targeted for 2025, and completion subject to regulatory and governmental approvals, aligning with BP’s strategy to streamline operations and enhance company value.

Bain Capital Announces $3.3B Acquisition of Mitsubishi Tanabe Pharma

Bain Capital has announced the signing of a definitive agreement to acquire Mitsubishi Tanabe Pharma Corporation in a carve-out transaction from Mitsubishi Chemical Group for approximately $3.3 billion. The investment, led by Bain Capital’s private equity and life sciences teams in Asia and North America, will enable the company to continue its legacy of medical innovation while pursuing growth through business development, licensing, and strategic acquisitions.

dsm-firmenich to Sell Feed Enzyme Alliance Stake to Novoesis

dsm-firmenich has announced the sale of its stake in the Feed Enzymes Alliance to Novonesis for €1.5 billion as part of its strategic portfolio realignment. The transaction, which includes a long-term commercial agreement for Novonesis to supply feed enzymes through dsm-firmenich’s global network, follows the planned separation of its animal nutrition & health business, with further divestment options expected in 2025.

Saint-Gobain Completes Acquisition of Fosroc

Saint-Gobain has finalised its acquisition of Fosroc, a prominent construction chemicals firm with a significant footprint in high-growth markets such as India, the Middle East, and Asia-Pacific. This deal, building on previous acquisitions of Chryso, GCP, and OVNIVER, enhances Saint-Gobain’s presence in the construction chemicals industry, with Fosroc generating $487 million in revenue in 2024 and broadening the company’s reach across 76 countries.

Univar Solutions Acquires Brad-Chem Holdings

Univar Solutions has acquired Brad-Chem Holdings, a UK-based leader in corrosion control products and lubricant additives, expanding its portfolio in specialty lubricant additives and multi-metal corrosion inhibitors. The acquisition strengthens Univar Solutions' European presence by integrating Brad-Chem’s specialty products and additive blending capabilities with its global distribution network, enhancing its offering in lubricants, metalworking fluids, coatings, adhesives, sealants, and elastomers.

Arcadium Lithium Secures Regulatory Approvals for Rio Tinto Acquisition 

Arcadium Lithium has received all required regulatory approvals to proceed with its acquisition by Rio Tinto, including merger control clearances in Australia, Canada, China, Japan, South Korea, the UK, and the US. The Royal Court of Jersey will hold a sanction hearing on 5 March 2025, with the transaction expected to close on 6 March 2025, marking a significant step in consolidating Arcadium Lithium’s role in the global lithium chemicals market.

Kurita America to Merge with Avista Technologies 

Kurita America, a provider of water treatment solutions, will merge with its sister company, Avista Technologies, on 1 April 2025. Avista, based in San Marcos, California, specialises in membrane treatment solutions and process support, and its integration with Kurita America will enhance their ability to serve industrial and municipal markets with an expanded portfolio of water treatment solutions.

Resonac Sells Resonac Packaging Corporation to Dai Nippon Printing

Resonac Corporation has transferred all shares of its subsidiary, Resonac Packaging Corporation, to Dai Nippon Printing (DNP) as of 3 February 2025. The divestment aligns with Resonac’s long-term strategy to optimise its business portfolio, with DNP’s expertise in packaging materials expected to drive further growth and innovation in secondary battery and food packaging solutions.

Sika Acquires Elmich Pte Ltd  

Sika has acquired Elmich Pte Ltd, a Singapore-based supplier of urban greening systems, to enhance its roofing portfolio and specification business in the Asia-Pacific region. The acquisition leverages Elmich’s expertise in green roof solutions to support sustainable urban development and expand Sika’s presence in commercial and residential projects.

JFE Engineering Acquires 66.6% of Sumitomo Chemical Engineering

JFE Engineering will acquire a 66.6% stake in Sumitomo Chemical Engineering by 31 March 2025 to strengthen its presence in the chemical plant engineering sector. The acquisition aligns with its strategic focus on expanding customer reach and service offerings amid global efforts toward a carbon-neutral society.

Indorama Ventures Completes Acquisition of the KEMELIX® and FLOWSOLVE® Brand Business from Cargill

Indovinya, a global business division of Indorama Ventures, has finalised the acquisition of the KEMELIX® and FLOWSOLVE® brand business from Cargill Bioindustrial UK, strengthening its specialty surfactants portfolio. The transaction includes trademarks, customer relationships, patents, tolling rights, and an R&D facility in Houston, Texas, expanding Indovinya’s capabilities in demulsifiers and flow assurance solutions for the oil and gas sector.

Lugman Group Withdraws from Purchase of Industrial Park Fechenheim

Clariant has announced that the Lugman Group has withdrawn from the acquisition of the Industrial Park Fechenheim due to the city of Frankfurt exercising its pre-emption rights. The transaction, initially expected to generate EUR 95 million in cash and a CHF 70 million boost in EBITDA for 2025, will not proceed, though Clariant remains committed to divesting the site.

Eigenmann & Veronelli Group Acquires Minority Stake in Cornelius Group

Eigenmann & Veronelli (EV) Group, a specialty chemicals and food ingredients distributor and manufacturer, has acquired a minority stake in Cornelius Group, a distributor of specialty additives and ingredients for life sciences and performance chemicals. The partnership strengthens both businesses by leveraging shared technical expertise and complementary strengths. It expands EV Group’s presence in the UK and Poland while providing Cornelius with a broader product range across manufacturing and distribution.

Waterland Private Equity Invests in SIDG

Lavollée Group, Sipa A.Ch., and Firmalis, key players in the distribution of specialty ingredients, have partnered with investment fund Waterland to form SIDG, a pan-European specialty ingredients distribution group. The investment supports SIDG’s growth strategy while maintaining its family business model and leveraging Waterland Private Equity’s expertise to strengthen its market position in food, nutrition, health, cosmetics, pharma, and industrial applications.

Lantheus to Acquire Evergreen Theragnostics

Lantheus has signed an agreement to acquire Evergreen Theragnostics in an all-cash transaction worth $250 million, with up to $752.5 million in potential milestone payments. The acquisition enhances Lantheus’ radiopharmaceutical manufacturing capabilities, expands its oncology diagnostic pipeline, and strengthens its position as a fully integrated radiopharmaceutical company.

Cormica Expands US presence with Acquisition of Focus Laboratories

Cormica has acquired Focus Laboratories, a microbiological testing firm with facilities in Allentown, Pennsylvania, and Palm Harbor, Florida. This acquisition follows Cormica’s recent purchase of Zwisler Laboratorium in Germany, strengthening its footprint in the US and Europe and expanding in pharmaceutical, biotech, and medical device testing capabilities.

Sumitomo Chemical Acquires France-Based Philagro Holding

Sumitomo Chemical has acquired all shares of Philagro Holding, its France-based subsidiary specialising in crop protection sales. The acquisition will enable Sumitomo Chemical to integrate operations with Sumitomo Chemical Agro Europe and explore M&A opportunities to expand its European market presence.

Sumitomo Chemical Acquires Kenogard

Sumitomo Chemical has agreed to acquire Kenogard, its Spanish crop protection sales subsidiary, as part of its strategy to integrate operations with Philagro under Sumitomo Chemical Agro Europe. Originally acquired in 1992 by Japanese firms, including Sumitomo Chemical, Kenogard operates as a joint venture with Nissan Chemical. This move strengthens Sumitomo’s presence in key agricultural markets in France and Spain.

Poland-based Grupta Azoty Signs Agreement to Sell Polyolefins PDH/PP Plant to Orlen

Grupa Azoty has signed an agreement with Orlen for the potential sale of its Polyolefins PDH/PP plant. The deal includes terms for due diligence and negotiations, which will continue through March 2025 as part of Grupa Azoty's recovery programme to establish a new business model for the group.

Cormica Acquires Zwisler Laboratorium

Cormica, a global life sciences testing and consulting company, has completed the acquisition of Zwisler Laboratorium, a provider of laboratory services. This acquisition marks Cormica's entry into the German market. It aligns with Cormica's strategy to expand its presence in high-growth European markets and enhance its service offerings for life sciences.

Adeka Sells Adeka Fine Chemicals (Shanghai) Co. Ltd to Shanghai Shengkui Plastics Products

Adeka Corporation has sold Adeka Fine Chemicals (Shanghai) to Shanghai Shengkui Plastics Products. The sale supports Adeka's strategy to streamline operations and adapt to environmental regulations in China, while developing its business as a base for PVC stabilisers, plasticisers, hardeners for epoxy resins, and other products, meeting market needs in the resin industry, automobiles, home appliances, and electronics-related fields.

Evonik Announces Smart Effects as a Strategic Merger of Silica and Silanes Business Line

Evonik has merged its Silica and Silanes business lines to form Smart Effects, effective 1 January 2025, to enhance customer solutions and strengthen sustainability. The new business line will streamline operations for improved efficiency and support markets such as automotive, electronics, and consumer health, while advancing sustainability and circularity in key sectors.

Lindus Health Raises $55M in Series B Funding 

Lindus Health has raised $55M in series B funding, led by Balderton Capital, to accelerate its AI-driven clinical trial platform. The funding will enhance Lindus Health’s proprietary eClinical platform, Citrus™, enabling faster trial execution, automated biostatistics, and hiring key talent to revolutionise the traditional CRO model.

PQ Corporation Acquires Swedish Specialty Silicate Business

PQ Corporation has acquired the Swedish Specialty Silicate business from the Sibelco Group, including operations at the Lödöse plant. This acquisition strengthens PQ’s European network and expertise in silicate production, enhancing its ability to serve customers in the Nordics.

Quadria Capital Acquires a Minority Stake in Aragen

Quadria Capital has invested $100 million to acquire a minority stake in Aragen, valuing the company at $1.4 billion. The valuation reflects a fresh infusion of capital, with a small portion attributed to the sale of shares by existing investors. This funding will empower Aragen to enhance its capabilities and infrastructure, meeting the growing demand for outsourcing services across the US and Europe.



DuPont Accelerates Electronics Spin-Off, Retains Water Business

DuPont has announced plans to expedite the spin-off of its Electronics business by 1 November 2025, while retaining its Water business, reflecting a strategic focus on enhancing shareholder value. This move underscores the significance of the Electronics segment to value creation and DuPont's commitment to optimising its portfolio through a swift separation process.

 

Cube Biotech Acquires IBA Lifesciences

Cube Biotech has acquired IBA Lifesciences to form a unified entity focused on advancing life science research and production. The acquisition combines expertise in protein purification and stabilisation, creating a robust foundation for innovation in drug discovery and biotechnology solutions.

The Mosaic Company to Sell Phosphate Mining Unit in Brazil

The Mosaic Company has entered into an agreement to sell its phosphate mining unit in Patos de Minas, Brazil to Fosfatados Centro for $125 million in cash over six years. This transaction aligns with Mosaic’s strategy to monetise non-core assets and redeploy capital, while Fosfatados Centro will assume full responsibility for the mine and tailings dams post-acquisition.

Weekly Highlights:

14th January 2025

Crystal Crop Protection Acquires Herbicide Ethoxysulfuron from Bayer

Crystal Crop Protection has acquired the herbicide active ingredient ethoxysulfuron from Bayer AG, along with the ‘Sunrice’ trademark and associated mixture products. This acquisition, Crystal's 13th strategic purchase, is projected to increase earnings by 20% and expand the company’s presence across selected Asian markets, including India, Vietnam, and Thailand.

DKSH Acquires CLMO Technology

DKSH has acquired CLMO Technology, a Malaysia-based ISO 17025 calibration and test laboratory service provider. The acquisition strengthens DKSH’s presence in the semiconductor and scientific solutions sectors, with 75% of CLMO's sales attributed to technology and the remainder supporting scientific growth in Malaysia and Vietnam.

Altaris to Acquire U.S. and U.K. Cell Therapy Business from WuXi AppTec

Altaris has entered a definitive agreement to acquire the U.S. and U.K. operations of Wuxi Apptec’s Advanced Therapies unit, with the transaction expected to close in the first half of 2025. This acquisition aligns with Altaris’ focus on the cell therapy sector, enhancing its portfolio with advanced capabilities, including viral vector manufacturing and FDA-approved T cell therapy production for solid tumour cancers.

BASF to sell Styrodur Business to BACHL

BASF has signed an agreement to sell its Styrodur business, including the brand and associated assets, to BACHL, a leading insulation materials producer in Germany. The sale supports BASF’s strategy to focus on expandable polystyrene products, with affected employees remaining with BASF and completion expected by mid-2025, subject to regulatory approvals.

Syngenta Crop to Divest FarMore Technology Platform to Gowan SeedTech

Syngenta Crop Protection has agreed to sell its FarMore Technology Platform to Gowan Seedtech, transferring trademarks, recipes, and other assets. This divestment enhances Gowan’s focus on servicing vegetable growers and enables Syngenta to concentrate on active ingredient innovation.

Howard Energy Partners Acquires Ethylene Pipeline from EPIC Midstream Holdings

Howard Energy Partners has completed the acquisition of the ethylene pipeline from Epic Midstream Holdings, enhancing its Gulf Coast presence. The 120-mile pipeline integrates with HEP’s Javelina Plant, creating operational synergies and advancing its diversification strategy.

Barentz Acquires NCD Ingredients

Barentz has acquired 100% of NCD Ingredients GmbH, a leading distributor of personal and home care ingredients in the DACH region, significantly strengthening its presence in Germany and enhancing its portfolio with high-quality raw and active ingredients. This strategic acquisition leverages NCD Ingredients’ blue-chip principals and complementary product range, enabling Barentz to expand its market penetration and deliver innovative solutions to the personal care and home care sectors across Europe.

Weekly Highlights:

17th December 2024

Eternis Fine Chemicals Acquires Sharon Personal Care

Eternis Fine Chemicals (Eternis) has successfully acquired Sharon Personal Care (Sharon PC), which has manufacturing capabilities in Italy and Israel and distribution sites in the US, Italy, Germany, and France. This acquisition marks Eternis’ further expansion of its portfolio and global distribution network in the growing personal care segment. 

Omya Acquires Distrupol from GPD Companies

Omya has entered into a definitive agreement to acquire Distrupol from GPD Companies, a leading global group of value-added distributors. Distrupol, a prominent European distributor of thermoplastics and elastomers, has expanded its presence significantly across the UK, Ireland, the Nordics, Benelux, and Egypt through strategic acquisitions over the past three years.

Eneos Acquires Full Ownership of ENEOS MOL Synthetic Rubber

ENEOS has signed an agreement to acquire MOL’s 49% stake in ENEOS MOL Synthetic Rubber (EMSR), resulting in full ownership of the company. The EMSR plant, operational since 2020 with a 60 ktpa capacity, was initially developed as part of a joint venture between MOL and JSR Corporation of Japan.

Styrenix to Acquire INEOS Styrolution’s Thailand Operations

Styrenix Performance Materials will acquire INEOS Styrolution’s 100% equity interest in its acrylonitrile butadiene styrene (ABS) and styrene acrylonitrile (SAN) production site in Thailand. The transaction aligns with INEOS Styrolution’s strategic focus on core styrenics operations and adds to their high-performing portfolio of styrene monomer, polystyrene, ABS, and advanced styrenic products. 

India Resurgence Fund Acquires a Majority Stake in Anthea Aromatics

India Resurgence Fund (IndiaRF) has invested INR 1,000 crores to acquire a controlling stake in Anthea Aromatics Private Limited. This marks IndiaRF’s second investment in the specialty chemicals sector and the first investment from its second fund, highlighting its focus on India-centric themes like domestic consumption and core manufacturing. 

Weekly Highlights:

10th December 2024

H.B. Fuller Acquires Medifill

H.B. Fuller has signed agreements to acquire Medifill, an Irish producer of medical-grade cyanoacrylate adhesives. This acquisition strengthens Fuller’s position in medical adhesive technologies, establishing a European headquarters and expanding its portfolio toward high-growth, high-profit markets. Combined, the acquisitions are expected to generate 2024 net revenue of €23 million and adjusted EBITDA of €11.5 million, with a purchase price of €180 million.

H.B. Fuller Acquires GEM S.r.l.

H.B. Fuller has agreed to acquire GEM, an Italian leader in medical adhesives and innovative application devices. This move enhances Fuller’s medical adhesive technologies business by leveraging GEM’s expertise in over 80 internal indications and builds upon prior investments in tissue adhesive markets, such as Cyberbond and Adhezion Biomedical. The acquisition supports Fuller’s strategy to diversify geographically and focus on next-generation solutions for wound closure and internal applications.

PPG Completes the Sale of Architectural Coatings U.S. and Canada Business to American Industrial Partners 

PPG has completed the sale of its architectural coatings business in the U.S. and Canada to American Industrial Partners for $550 million. This divestiture optimises PPG’s portfolio, allowing greater focus on its core operations in other regions and improving growth and financial return profiles through streamlined resources and strategic focus.

Roche Acquires Poseida Therapeutics

Roche has entered into a merger agreement to acquire Poseida Therapeutics for $9.00 per share in cash, with contingent payments of up to $4.00 per share upon meeting specific milestones, valuing the deal at $1.5 billion. The acquisition will bolster Roche’s expertise in allogeneic cell therapy, adding Poseida’s CAR-T programs for cancer and autoimmune diseases, as well as its innovative genetic engineering platform.

CBC Group Acquires UCB’s Mature Neurology and Allergy Business in China

CBC Group, in partnership with Mubadala, has acquired UCB’s neurology and allergy business in China, including its Zhuhai manufacturing site and brands like Xyzal and Keppra, for $680 million. The acquisition, which includes forming NeuroGen Pharma, aims to establish a CNS-focused biopharma platform and enhance healthcare services in China’s growing therapeutic market.

INEOS Sells INEOS Composites to KPS Capital Partners

INEOS has agreed to sell its composites business to KPS Capital Partners for approximately €1.7 billion, subject to regulatory approvals and consultations. The business, generating €800 million annually, operates across 17 sites globally and offers advanced resin solutions for diverse industrial applications.

Arkema Successfully Acquires Dow’s Flexible Packaging Laminating Adhesives Business

Arkema has finalised the acquisition of Dow’s flexible packaging laminating adhesives business, valued at $150 million, significantly expanding its portfolio in the packaging market. The acquisition, encompassing operations in North America and Europe, includes advanced production sites and will strengthen Arkema’s market presence in food and medical applications.

Sipcam Oxon Acquires Grosafe Chemicals

Sipcam Oxon has acquired Grosafe Chemicals, a New Zealand-based agrochemical company, enhancing its global presence in sustainable agriculture by integrating Grosafe’s local expertise with its operations. Additionally, its entry into Japan and innovations like N-Catch, featuring the nitrogen-fixing microbe Gluconacetobacter diazotrophicus, align with its mission to support on-farm profitability and sustainability.

Weekly Highlights:

3rd December 2024

Arlington Capital Partners Acquires TEAM Technologies

Arlington Capital Partners has acquired TEAM Technologies, a global manufacturer of essential healthcare products, from Clearlake Capital Group. TEAM provides outsourced design and manufacturing services to medical device and pharmaceutical OEMs, specialising in advanced medical devices critical to healthcare systems. The acquisition aligns with Arlington's strategy to strengthen healthcare supply chains and enhance TEAM’s solutions for medical and pharmaceutical clients.

Novartis Acquires Kate Therapeutics for $1.1B

Novartis has acquired Kate Therapeutics, a biotechnology company specialising in gene therapies for neuromuscular diseases, in a deal worth up to $1.1 billion. The acquisition strengthens Novartis’ gene therapy and neuroscience innovation capabilities, targeting unmet medical needs. 

ANSA McAL Acquires US-Based BleachTech LLC 

LBC Tank Terminals has acquired Evolution Terminals, advancing its energy transition strategy with plans for a renewable energy terminal in the port of Vlissingen in the Netherlands. This project will feature state-of-the-art ammonia storage and infrastructure, further positioning LBC as a leader in renewable energy logistics.

Arlington Capital Partners Acquires TEAM Technologies

Arlington Capital Partners has acquired TEAM Technologies, a global manufacturer of essential healthcare products, from Clearlake Capital Group. TEAM provides outsourced design and manufacturing services to medical device and pharmaceutical OEMs, specialising in advanced medical devices critical to healthcare systems. The acquisition aligns with Arlington's strategy to strengthen healthcare supply chains and enhance TEAM’s solutions for medical and pharmaceutical clients.

Novartis Acquires Kate Therapeutics for $1.1B

Novartis has acquired Kate Therapeutics, a biotechnology company specialising in gene therapies for neuromuscular diseases, in a deal worth up to $1.1 billion. The acquisition strengthens Novartis’ gene therapy and neuroscience innovation capabilities, targeting unmet medical needs. 

ANSA McAL Acquires US-Based BleachTech LLC 

LBC Tank Terminals has acquired Evolution Terminals, advancing its energy transition strategy with plans for a renewable energy terminal in the port of Vlissingen in the Netherlands. This project will feature state-of-the-art ammonia storage and infrastructure, further positioning LBC as a leader in renewable energy logistics.

Aon to Acquire Mitsubishi Chemical’s In-House Insurance Agency 

Aon has entered into a definitive agreement to acquire the in-house insurance agency business of Mitsubishi Chemical Group (MCG), enhancing its risk and health capabilities in Japan. The divestiture enables MCG to focus resources and investments on its core operations while benefiting from Aon's global risk management expertise to enhance its governance.

Adragos Pharma Successfully Acquires Swiss CDMO Baccinex

Adragos Pharma has acquired Baccinex, a Swiss CDMO specialising in aseptic fill-finish and lyophilization, significantly enhancing its sterile manufacturing capabilities. This acquisition, which adds a sixth global site to Adragos’ network, strengthens its position as a global partner of choice for high-quality pharmaceutical manufacturing. 

Safic-Alcan Acquires Majority Stake in Avees Biocos

Safic-Alcan has acquired a majority stake in Avees Biocos, an Indian distributor of personal care chemicals, as part of its strategy to expand in the Asia Pacific region. This partnership builds on their existing relationship and enhances Safic-Alcan’s global personal care footprint, leveraging Avees Biocos’ expertise and innovation centre in Gurugram.

Weekly Highlights:

26th November 2024

ICIG and Vynova Group Acquires the European Advanced Organics Business from Valtris Specialty Chemicals

ICIG and Vynova Group have acquired the European advanced organics business from Valtris Specialty Chemicals, including production plants in Belgium and the Netherlands. This strategic acquisition integrates the advanced organics business into Vynova Group, enhancing its portfolio with key chemical intermediates used in a large number of markets such as coatings, flavour & fragrance, personal care, agrochemicals, and pharmaceutical applications. 

Sun A. Kaken Acquires Resonac’s Surface Protection Film Business

Sun A. Kaken has completed the acquisition of Resonac Corporation’s surface protection film business. This transaction aligns with Resonac’s long-term vision to optimise its business portfolio, ensuring sustainable growth while leveraging Sun A. Kaken’s expertise in plastic film processing.

ANSA McAL Acquires US-Based BleachTech LLC 

ANSA McAL has acquired chlor-alkali producer BleachTech LLC for $327 million, marking the Caribbean conglomerate’s largest acquisition in its history. This move expands ANSA McAL’s market reach into North America, complementing its leadership in the Caribbean chemical industry and enhancing its focus on sustainable water treatment solutions.

Azelis Acquires Haarla Oy

Azelis has announced the acquisition of Haarla Oy, a Finland-based distributor of food ingredients and industrial chemicals, marking a strategic move to enhance its portfolio in the Nordics. Haarla Oy's strong presence in food ingredients, its 300+ customer base, and longstanding principal relationships align well with Azelis’ growth strategy and product portfolio in life sciences and industrial chemicals.

Sayona Mining Merges with US-based Piedmont Lithium 

Sayona Mining and Piedmont Lithium have announced their merger as a 50/50 all-stock transaction to create a leading North American hard rock lithium producer. The merger aims to unlock synergies, simplify corporate structures, and strengthen the balance sheet, with equity financing planned to support significant expansion opportunities.

Amcor Acquires Berry Global for $8.4 Billion 

Amcor has agreed to acquire Berry Global in an all-stock transaction valued at $8.4 billion, combining their operations to create a global leader in consumer packaging solutions. This acquisition is expected to generate $24 billion in revenue and $4.3 billion in adjusted EBITDA while driving synergies through innovation, sustainability initiatives, and increased investment in R&D.

Symrise Offers to Acquire Probi

Symrise has announced a public offer to acquire all outstanding shares of Probi, a biotics solutions company listed on Nasdaq Stockholm. As Probi's largest shareholder since 2012, Symrise aims to integrate Probi into its health-focused strategy, leveraging its expertise to drive global growth in probiotics for functional foods and supplements.

Weekly Highlights:

18th November 2024

Maravai LifeSciences to Acquire Officinae Bio’s DNA and RNA Business

Maravai LifeSciences has announced the acquisition of Officinae Bio’s DNA and RNA business to enhance its nucleic acid-based therapy offerings. This acquisition complements Maravai’s expertise in nucleic acid production with Officinae Bio’s proprietary digital platform for rapid prototyping of mRNA candidates, expanding customer capabilities in therapeutic innovation.

Nippon Shokubai Acquires Emulsion Technology from JSR Corporation 

Nippon Shokubai has acquired JSR Corporation's emulsion business under the name E-TECH, marking a strategic expansion into construction chemicals. The acquisition leverages E-TECH’s expertise in adhesives and waterproofing polymers, aligning with Nippon Shokubai's industrial and household business growth.

SMC Global Acquires International Chemicals LLC

SMC Global has acquired International Chemicals LLC (ICC), integrating its oilfield business with ICC’s operations to enhance capabilities in oil and gas solutions. The merger includes a trucking fleet and ICC’s facilities in Texas, enabling efficient manufacturing and customer service.

Indorama Ventures Acquires Cargill’s KEMELIX and FLOWSOLVE brands

Indorama Ventures, through its Indovinya subsidiary, has acquired Cargill’s KEMELIX and FLOWSOLVE brands to expand its specialty surfactant portfolio. These brands strengthen Indorama’s offerings in demulsifiers and flow assurance products, critical for operational efficiency in energy extraction sectors.

Imerys Divests Paper Market Assets to Flacks Group 

Imerys, a leading global supplier of mineral-based specialty solutions, has completed the sale of its paper market assets to an affiliate of Flacks Group for approximately €150 million. This divestiture allows Imerys to focus on its growth strategy in specialty mineral solutions, particularly in energy transition, sustainable construction, and natural solutions for consumer goods.